|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.218 0.000 (0.000%) | 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 61,253 | 48.395% | 41,277 | 42,839 | 40,985 | 77,813 |
| Cost of Sales | (47,022) | 29.687% | (36,258) | (37,369) | (35,053) | (56,929) |
| Gross Profit | 14,231 | 183.543% | 5,019 | 5,470 | 5,932 | 20,884 |
| 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,060 | -- | (2,734) | 1,815 | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | (19,217) | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (1,131) | (21,889) | (10,796) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 186 | (153) | 3,588 | |
| Profit / (Loss) before Taxation | (1,079) | -94.693% | (20,332) | (11,407) | (94,158) | (111,064) | |
| Taxation | (291) | 250.602% | (83) | 1,307 | 387 | 558 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 388 | -- | -- | -- | |
| Non-controlling Interests | 503 | 52.888% | 329 | (535) | 5,773 | 4,166 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (867) | -95.599% | (19,698) | (10,635) | (87,998) | (106,340) | |
| 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 5,851 | -75.466% | 23,849 | 8,569 | 16,407 | 14,545 |
| Depreciation & Amortisation | 1,333 | -3.266% | 1,378 | 2,007 | 2,426 | 10,454 |
| Directors' Emoluments | 2,471 | -6.295% | 2,637 | 4,248 | 8,742 | 4,939 |
| 2025/06 - Final | %Chg (Compare to Final) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | Qualified | -- | Qualified | Qualified | Qualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2025/06 - Final | %Chg (Compare to Final) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -0.190 | -98.228% | -10.720 | -0.060 | -49.000 | -61.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.012) | -- | (0.050) | 0.026 | (0.204) | (0.001) |
| NBV per share ($) | (0.058) | -- | (1.086) | (0.940) | (0.919) | (0.788377) |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -867 |
| %Change | -95.599% |
| EPS / (LPS) | HKD -0.002 |
| NBV Per Share ($) | HKD -0.058 |